Lung
Non-small cell lung cancer chemotherapy treatment outcomes and ethnicity: a twenty-year single-centre patterns of care study
Aim:
To investigate the treatment of patients with advanced-stage non-small cell lung cancer (NSCLC) over a 20-year period in a sing...
Trends in lung cancer diagnosis and care among visible minorities and non-visible minorities in Canada
Background:
Identifying factors that influence the diagnosis and treatment of lung cancer is an important public health initiative. ...
Factors leading to disparity in lung cancer diagnosis among black/African American communities in the USA: a qualitative study
Objective:
This study has two objectives: first, to explore the diagnostic experiences of black/African American (BAA) patients with...
USPSTF, PLCO Lung Cancer Screening Models Similarly Sensitive for Indigenous People
Eligibility for lung cancer screening did not differ significantly among people who self-reported as Indigenous. These findings were published in C...
Lung Cancer Screening Among U.S. Military Veterans by Health Status and Race and Ethnicity, 2017-2020: A Cross-Sectional Population-Based Study
Introduction:
Veterans are at high risk for lung cancer and are an important group for lung cancer screening. Previous research sugg...
Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility
Importance:
Using race and ethnicity in clinical prediction models can reduce or inadvertently increase racial and ethnic disparitie...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
